发明名称 PHARMACEUTICAL COMPOUNDS
摘要 A compound of the formula see Formula in which R1 is hydrogen, halo, C1-4 alkyl, C1-4 alkoxy, nitrile, optionally protected carboxy, optionally protected tetrazolyl, trihalomethyl, hydroxy-C1-4 alkyl, aldehydo, - CH2Z, -CH=CH-Z or -CH2CH2Z where Z is optionally protected carboxy or optionally protected tetrazolyl; R2 is halo, nitrile, an optionally protected acid group or -CONR7R8 where R7 and R8 are each hydrogen or C1-4 alkyl; R3 and R4 are each hydrogen, C1-4 alkyl, optionally substituted phenyl, or C1-4 alkyl substituted by -CONR7R8 or an optionally protected acid group; R5 is see Formulas where W is -CH=CH-, -CH=N-, -N=CH-, -O- or -S-, R9 is hydrogen, halo, C1-4 alkyl, C1-4 alkoxy or trihalomethyl, and R10 is hydrogen, C1-4 alkyl, C2-6 alkenyl, C3-6 cycloalkyl or C1-4 alkyl-C3-6 cycloalkyl; R6 is hydrogen or C1-4 alkyl; X is -O-(CH2)n CR11CR12-, -CR11R12-, -CR11R12.(CH2)n.CR13R14- or -CR11=CR12- where R11, R12, R13 and R14 are each hydrogen or C1-4 alkyl, and n is 0, 1 or 2; and Y is -O-CR15R16-, -CR15=CR16- or -CR15 R16,CR17R18- where R15, R16, R17 and R18 are each hydrogen or C1-4 alkyl; or a salt thereof. The compounds in unprotected form are active as leukotriene antagonists.
申请公布号 CA2048096(A1) 申请公布日期 1992.02.01
申请号 CA19912048096 申请日期 1991.07.29
申请人 LILLY INDUSTRIES LIMITED 发明人 GILMORE, JEREMY;TODD, ALEC
分类号 A61K31/40;A61K31/33;A61K31/403;A61K31/404;A61K31/423;A61K31/425;A61K31/427;A61K31/428;A61K31/44;A61K31/4427;A61K31/4439;A61K31/4709;A61K31/498;A61K31/517;A61P9/00;A61P9/10;A61P11/06;A61P29/00;A61P37/08;A61P43/00;C07D209/32;C07D401/10;C07D401/12;C07D401/14;C07D403/10;C07D403/12;C07D403/14;C07D413/10;C07D413/12;C07D413/14;C07D417/10;C07D417/12;C07D417/14;(IPC1-7):C07D401/14;C07D401/06;C07F7/10;A61K31/395;A61K31/495;A61K31/695 主分类号 A61K31/40
代理机构 代理人
主权项
地址